Introduction
Equine herpesvirus-1 (EHV-1), a member of the Alphaherpesvirinae, is an important pathogen of horses, causing abortion, neonatal foal death, nervous system disorders and less frequently respiratory disorders. An extensive cellassociated viraemia during EHV-1 infection enables the virus to reach internal organs, even in the presence of virusneutralizing antibodies (Doll & Bryans, 1963 ; Mumford et al., 1987) . During viraemia, the virus is carried by peripheral blood mononuclear cells (PBMC), mainly by lymphocytes and to a lesser extent by monocytes, as described by Scott et al. (1983) .
Somewhat different from these results obtained in vivo by Scott et al. (1983) , we found during in vitro studies that the Author for correspondence : Hans Nauwynck.
Fax j32 9 264 74 95. e-mail hans.nauwynck!rug.ac.be majority of the EHV-1-infected equine PBMC are monocytes, whereas most of the lymphocytes are refractory to infection (van der Meulen et al., 2000) . However, mitogen stimulation of PBMC prior to EHV-1 infection increases the percentage of infected T-lymphocytes (van der Meulen et al., 2000) . The identity of the EHV-1-infected subtypes of mitogen-stimulated T-lymphocytes has not been determined so far.
The finding that mitogen stimulation increases the number of infected T-lymphocytes led to the hypothesis that EHV-1 replication in T-lymphocytes might benefit from a specific phase of the cell cycle, induced by mitogen stimulation. Cell cycle-dependent replication has already been demonstrated for several herpesviruses. For example, herpes simplex virus (HSV) needs one or more cyclin-dependent kinases, active from late G " onward and required for cellular progression into the Sphase, for the accumulation of HSV transcripts, viral DNA replication and production of infectious virus (Schang et al., 1998 (Schang et al., , 1999 (Schang et al., , 2000 . Cyclin-dependent kinases are also required for the replication of human cytomegalovirus (HCMV) (Bresnahan et al., 1997) . An effect of the cell cycle on the replication of EHV has already been described by Lawrence (1971) in a human carcinoma cell line. He showed that synthesis of EHV DNA takes place only when the cells are in or just entering the S-phase of the cell cycle. McCulloch et al. (1993) demonstrated an increase in the percentage of blastic cells of up to 40 % in the blood circulation of experimentally inoculated horses during a time period coinciding with the viraemic phase of an EHV-1 infection. Cell cycle-dependent replication of EHV-1 may be an important pathogenic feature during an infection in vivo.
The main purpose of this study was to identify the EHV-1-infected subtype(s) of mitogen-stimulated PBMC in vitro and to obtain better insights in the mechanism(s) by which mitogen stimulation affects the course of an EHV-1 infection.
Methods
PBMC. Blood samples were obtained from infection-immune horses by jugular venipuncture and collected on heparin (Leo, Zaventem, Belgium). PBMC were then isolated by density centrifugation on FicollPaque (Pharmacia). Cells were washed three times with PBS and resuspended in medium [RPMI 1640, 10 % foetal calf serum, 0n05 mM 2-mercaptoethanol, 100 U\ml penicillin, 0n1 mg\ml streptomycin, 0n1 mg\ml kanamycin, 1 % non-essential amino acids 100i (GibcoBRL), 1 mM sodium pyruvate, 1 % glutamine].
Virus and in vitro infection. The Belgian EHV-1 strain 97P70 was used in all experiments (van der Meulen et al., 2000) . Virus used for inoculation was at the fifth passage on equine embryonic lung (EEL) cells and one subsequent passage on rabbit kidney (RK13) cells.
PBMC were infected at an m.o.i. of 10. After 1 h of incubation at 37 mC, the cells were washed thoroughly with RPMI and cultured in medium supplemented with 10 U\ml heparin with or without addition of mitogens.
Mitogen stimulation. In a previous study, we demonstrated that the highest number of EHV-1 antigen-positive PBMC was obtained after stimulation with a combination of the phorbol ester phorbol 12,13-dibutyrate (PDB), and the calcium ionophore ionomycin (IONO) (van der Meulen et al., 2000) . Therefore, IONO and PDB were used throughout the experiments in the current study. PBMC were stimulated with 0n5 µM IONO and 10 nM PDB (Sigma) in medium as decribed earlier.
Mitogen stimulation was performed before or during EHV-1 infection, depending on the experiment.
Detection of viral antigen-positive PBMC. The percentage of EHV-1 antigen-positive cells was determined by indirect immunofluorescence staining on acetone-fixed cell smears. Cells were incubated for 1 h at 37 mC, first with mouse polyclonal antibodies against EHV-1 and after three washing steps in PBS with goat anti-mouse antibodies labelled with fluorescein isothyocyanate (FITC). Samples were analysed with a Leica DM BRE fluorescence microscope. At least 200 cells were counted for each sample.
Cell cycle analysis. Cells were fixed in ice-cold ethanol (70 %) for 30 min, washed with PBS and stained for 30 min at room temperature with a solution containing 10 µg\ml propidium iodide, 0n1 % Triton X-100, 2 mM MgCl # , 0n1 M NaCl, 10 mM PIPES buffer and 20 units\ml RNase A in distilled water. The cells were analysed by flow cytometry using a Becton Dickinson FACSCalibur and BD Cellquest software. The following parameters were stored for further analysis : FSC, SSC, FL2-W and FL2-A. Gates were placed, based on FSC and SSC profiles, to include viable cells only. At least 5000 cells were analysed for each sample.
Identification of the EHV-1-infected, mitogen-stimulated PBMC. A double immunofluorescence staining was performed in two steps. First, the cells were fixed in paraformaldehyde (3 %), washed with PBS and incubated for 1 h with one of the following monoclonal antibodies : HT23A (anti-equine CD5), HB61A (anti-equine CD4), 73\6.9.1 (anti-equine CD8) or DH59B (equine monocyte marker) (VMRD, Pullman, WA, USA). Then, an FITC-conjugated goat antimouse antibody was added for 1 h. To stain the B-lymphocytes an FITClabelled goat anti-horse IgM antibody (Kirkegaard & Perry Laboratories) was used. After the first step, the cells were washed in PBS and permeabilized with saponin (0n1 %). Then, the cells were incubated for 1 h with protein G-purified and biotinylated horse antibodies raised against EHV-1 and finally with Texas Red-or phycoerythrin-labelled streptavidin (Molecular Probes). An irrelevant monoclonal antibody 41D3 against a putative receptor for a porcine arterivirus (Duan et al., 1998) as well as a non-infected sample were included as controls.
Staining was performed either in suspension or within the chambered coverglass (Nunc) in which some PBMC samples had been stimulated with mitogens and subsequently infected ; the latter procedure prevented loss of existing contacts between cells. For cells in suspension, all manipulations were performed at 4 mC. Samples were analysed by flow cytometry. Four parameters were stored for further analysis : FSC, SSC, FL1 and FL2. Gates were placed, based on FSC and SSC profiles, to include viable cells only. At least 10 000 cells were analysed for each sample. Within the chambered coverglass, all manipulations during the staining were performed at room temperature. Cells were analysed within their recipient with a Leica DM IL inverted fluorescence microscope. At least 100 cells or cell groups were counted for each sample. Additionally, cells were analysed with a Bio-Rad Radiance 2000 confocal laser scanning system linked to a Nikon Diaphot 300 microscope.
Results

Identification of the EHV-1-infected, IONO/PDBstimulated PBMC by flow cytometry
PBMC were simultaneously stimulated and infected. Cells were collected at 48 h post-inoculation (p.i.) and a double immunofluorescence staining was performed. The percentages of the different cell types within the total population of PBMC and within the population of EHV-1 antigen-positive PBMC are shown in Table 1 .
The total population of PBMC consisted mainly of CD5 + T-lymphocytes (including CD4 + and CD8 + T-lymphocytes), with B-lymphocytes the next largest fraction. Monocytes formed the smallest fraction of the PBMC. With the markers used in this experiment, 36n9 % of the PBMC could not be identified.
Most of the EHV-1 antigen-positive cells were CD5 + Tlymphocytes, with B-lymphocytes the next largest fraction. The smallest fraction of the EHV-1 antigen-positive cells were monocytes. Thirty-five percent of the infected cells could not be identified. The composition of EHV-1-infected PBMC reflected well the composition of the total population of PBMC. 
Replication of EHV-1 in PBMC stimulated with IONO/PDB for different time periods prior to inoculation
PBMC were stimulated for 0, 12, 24 or 36 h and subsequently infected. Stimulation was continued after inoculation. Non-stimulated PBMC were included as a control. Cells were collected at 0, 12 and 24 h p.i. Table 2 shows the distribution of cells in the different stages of the cell cycle (G ! \G " , S, G # \M) at the time-point of inoculation with EHV-1 and the percentage of EHV-1 antigen-positive cells at different time-points after inoculation for the PBMC of three different infection-immune horses.
Based on the results of the five experiments, the mean percentage of PBMC in the G ! \G " -phase of the cell cycle decreased from 98n2p1n0 % before stimulation to 93n3p1n3% after 36 h of stimulation. The mean percentage of PBMC in the S-and G # \M-phase increased from 1n5p1n2 % and 0n4p0n1% respectively before stimulation to 5n7p0n8 % and 1n1p0n5% respectively after 36 h of stimulation.
Owing to the large biological variation observed between the individual experiments, significant differences were not found between the absolute mean percentages of EHV-1 antigen-positive cells in the 0, 12, 24 or 36 h-prestimulated samples and the non-stimulated control at 12 h p.i. However, when relative values were calculated based on the data from the individual experiments and with the non-stimulated control as a reference value of 1, a significant difference was observed between the 36 h-prestimulated PBMC and the control (relative values were 0n9p0n2, 1n9p1n0, 2n3p0n7 and 3n1p2n3 for the 0, 12, 24 and 36 h-prestimulated samples respectively). At 24 h p.i., a significant difference was observed between the absolute percentages of viral antigen-positive cells in the 12, 24 and 36 h-prestimulated samples and the non-stimulated control. For the relative values, a significant difference was found between the 24 and 36 h-prestimulated samples on the one hand and the non-stimulated control on the other hand (relative values were 1n6p0n5, 5n7p2n9, 9n1p5n3 and 9n7p7n8 for the 0, 12, 24 and 36 h-prestimulated samples respectively). Statistical analysis was based on the least significant difference (LSD ; rejection level 0n050).
A 
Formation of clusters of PBMC by stimulation with IONO/PDB
When PBMC were stimulated with IONO\PDB, intercellular contacts were initiated which resulted in the formation of aggregates or clusters of PBMC, consisting of at least two to more than 50 cells (Fig. 1 a) . Clusters became manifest Table 3 . EHV-1 replication within clusters of IONO/PDB-stimulated PBMC PBMC were stimulated for 24 h prior to EHV-1 inoculation. All data are expressed as the mean value of five experimentspSD. between 12 and 24 h after addition of IONO\PDB and remained clearly visible till at least 60 h after IONO\PDB addition (end of the experiment).
Percentage of clusters of PBMC with … adjacent infected cells
Time postinoculation (h) 0 1 2 3 4 8 8 3 n3p2n7 15n1p3n5 1 n6p1n1 0 0 17 62n6p9n5 24n1p4n5 7 n9p1n8 3 n0p2n7 2 n5p1n3 24 60n6p5n2 25n3p4n3 9 n9p1n9 3 n6p0n6 0 n6p0n9
EHV-1 replication in clusters of IONO/PDB-stimulated PBMC
PBMC were stimulated for 24 h and infected afterwards. At 8, 17 and 24 h p.i., a double immunofluorescence staining was carried out. The results are shown in Table 3 . At 8 h p.i., most of the infected clusters contained one viral antigen-positive cell (Table 3 ; Fig. 1 b) . Between 8 and 17 h p.i., a 2n2-fold increase in the percentage of clusters with infected cells was seen and the number of adjacent infected cells per cluster increased from a maximum of two to a maximum of four (Table 3 ; Fig. 1 c, d ).
The percentages obtained at 24 h p.i. were similar to those obtained at 17 h p.i. By using confocal laser scanning microscopy, the presence of close intercellular contacts between adjacent infected cells was visualized in more detail, as shown in Fig. 2 (a, b) .
Between 8 and 17 h p.i., an increase was seen in the percentage of clusters containing one infected cell (Table 3) . Identification with DH59B, an equine monocyte marker, revealed that this increase was caused by an increase in the percentage of clusters containing one infected cell, not belonging to the monocytes (from 10n5p4n1 % at 8 h p.i. to 19n3p4n0 % at 17 h p.i.). The percentage of clusters containing one infected monocyte, on the other hand, remained at a constant level (4n6p1n3 % at 8 h p.i. and 4n9p1n0 % at 17 h p.i.). The percentages obtained at 24 h p.i. were similar to those obtained at 17 h p.i.
A similar pattern was seen in the population of cells that remained individual in the recipient, without any visual contact to other cells. In the population of cells not belonging to the monocytes an increase was seen in the percentage of viral antigen-positive cells between 8 (2n2p1n1 %) and 24 h p.i. (6n9p6n0 %), whereas a constant number of monocytes was infected during the entire course of the EHV-1 infection (10n0p4n0, 11n0p2n1 and 11n1p3n4 % at 8, 17 and 24 h p.i. respectively).
In clusters with two or more infected cells in contact, the infected cell groups consisted of either monocytes and nonmonocytes or non-monocytes only (maximum 6n8p4n0 and 7n6p3n6 % of all the clusters respectively). Clusters consisting of two or more infected monocytes formed 1n3p1n0 % of all the clusters.
Discussion
The present study shows that stimulation of equine PBMC with IONO\PDB affects an EHV-1 infection in two ways. First, stimulation initiates proliferation events in lymphocytes, which enable EHV-1 to replicate in a limited number of cells. Second, stimulation induces the formation of aggregates or clusters of PBMC. The close interactions between the PBMC within these clusters facilitate the transmission of EHV-1 from an infected cell to an uninfected adjacent cell.
EHV-1 infection was studied in a population of PBMC stimulated with IONO\PDB for different time periods prior to virus inoculation. PBMC were isolated from infection-immune, seropositive horses ; therefore they may be assumed to be latently infected. It has been reported that latent EHV-1 can be reactivated in vitro from leukocytes by the mitogens phytohaemagglutinin and pokeweed mitogen, as detected by cocultivation and immunofluorescence (Smith et al., 1998) . Since IONO\PDB also acts as a mitogen, it is reasonable to suggest that these products induced reactivation of EHV-1 in the leukocytes of the three infection-immune horses, thereby confounding the results of the present study. However, to exclude an influence of reactivation of latently infected leukocytes on the percentage of viral antigen-positive cells, we always determined the percentage of EHV-1 antigen-positive cells in uninoculated PBMC after 0, 12, 24 and 36 h of stimulation (0 h p.i.). No viral antigen-positive cells were detected (Table 2) . Therefore, we may conclude that the stimulation with IONO\PDB did not cause a reactivation of EHV-1 and did not affect the percentage of EHV-1 antigenpositive cells.
Based on the relative values of viral antigen-positive cells at 12 h p.i., a significant difference was observed between the 36 h-prestimulated PBMC and the non-stimulated control. This suggests that stimulation with IONO\PDB induces one or more specific events that enable EHV-1 to replicate in a limited number of cells. Viral transmission from cell to cell, as discussed below, cannot account for the increase, since groups consisting of two or more adjacent viral antigen-positive cells occurred mainly from 14 h p.i. onwards (data not shown). Moreover, when EHV-1 replication was studied at 8 and 17 h p.i. in prestimulated PBMC, a 2-fold increase in the percentage of clusters containing one infected lymphocyte (from 10n5% at 8 h p.i. to 19n3 % at 17 h p.i.) as well as in the percentage of individually located, infected lymphocytes (from 2n2% at 8 h p.i. to 4n4 % at 17 h p.i.) was observed. Since there is no direct interaction with other infected cells, these observations support the idea that the increase in the percentage of infected cells is not caused by cell-to-cell transmission of the virus, but by another effect induced by the mitogens, for example one or more cell cycle-dependent events.
To determine whether the effect induced by IONO\PDB was related to the S-phase or the G # \M-phase of the cell cycle, the correlation coefficient (r) was calculated between the relative value of cells in the S-or G # \M-phase of the cell cycle at the moment of inoculation and the relative value of EHV-1 antigen-positive cells. A very high correlation (r l 0n974) was observed between the relative value of cells in the S-phase and the relative value of EHV-1 antigen-positive cells at 12 h p.i.
This means that an increase in the percentage of cells in the S-phase after a certain time interval of prestimulation is accompanied by a similar increase in the percentage of EHV-1 antigen-positive cells at 12 h p.i. Therefore, we assume that virus replication is facilitated during a specific stage of the Sphase of the cell cycle. This is consistent with a report by Lawrence (1971) , who found evidence for a relationship between EHV DNA synthesis and the S-phase of the cell cycle in KB cells, a human carcinoma cell line. Since most cells entering the S-phase will continue into the G # \M-phase, a significant, but lower correlation was found between the relative proportion of cells in the G # \M-phase and the relative proportion of EHV-1 antigen-positive cells at 12 h p.i. At 24 h p.i., there was still a significant correlation between the different phases of the cell cycle and the relative percentage of EHV-1 antigen-positive cells. However, the correlation coefficients were clearly lower than at 12 h p.i., suggesting that other effects are also involved at this time-point after inoculation.
We hypothesized that the close intercellular interactions formed within the clusters of IONO\PDB-stimulated equine PBMC favoured the transmission of EHV-1 from an infected to an uninfected adjacent cell. Our results show that EHV-1 was indeed transferred from infected cells to adjacent cells. At 8 h p.i., only 1n6 % of the clusters contained a group of adjacent infected cells, whereas this percentage increased significantly to 13n4 % at 17 h p.i. Moreover, the number of adjacent infected cells per cluster increased from a maximum of two at 8 h p.i. to a maximum of four at 17 and 24 h p.i. With confocal laser scanning microscopy the existence of close intercellular contacts between adjacent infected cells was confirmed. The exact mechanism by which EHV-1 is transmitted from one cell to another within the clusters of PBMC remains to be determined. Since addition of virus-neutralizing antibodies to the medium during infection did not alter the percentage of infected clusters or the number of adjacent infected cells per cluster (data not shown), we suggest that a direct cellassociated spread of the virus is involved. Since cluster formation seems to be required for transmission and since cluster formation depends on discrete interactions between cell adhesion molecules (reviewed by Hogg & Landis, 1993) , it seems likely that EHV-1 transmission relies on the close contacts initiated by cell adhesion molecules, as described for human immunodeficiency virus (Fais et al., 1995 ; TsunetsuguYokota et al., 1997) .
The results of the present study concerning the subfractions of lymphocytes that were scored as infected differed from those obtained by Scott et al. (1983) . However, it is important to mention that the study of Scott et al. was performed in vivo. They experimentally infected ponies to detect and quantify the in vivo presence of the virus in leukocytes. Cultivation and identification were performed on cells obtained from the infected ponies. In the present study, the interaction between leukocytes and EHV-1 was studied in vitro. Leukocytes were isolated from healthy horses and afterwards stimulated and infected in vitro. Furthermore, Scott et al. used infectious centre assays and plaque assays to detect the infected cells and therefore their results represent the ' productively infected ' leukocytes. In our experiments, immunofluorescence staining was used and therefore the results represent the ' viral antigenpositive ' leukocytes. In our previous report, we demonstrated that only 13n7 % of the viral antigen-positive monocytes and 5n3 % of the viral antigen-positive lymphocytes were productively infected. This means that the number of viral antigenpositive cells will be quite different from the number of productively infected cells. The above mentioned differences may be the cause of the disparity between the study of Scott et al. and the present study.
Remarkably, one-third of the PBMC could not be identified by the markers used in our experiments. This finding cannot be due to an effect of infection, since the same observation was made for non-infected cells (30n1p5n7 % unidentified). Modulation of the expression of cell surface molecules in response to phorbol esters has been described in horses by Zhang et al. (1994) . Since they found that PMA-mediated down-regulation of CD4 expression was reversible and the percentage of CD4 + molecules was returned to control levels after 48 h (Zhang et al., 1994) , it seems unlikely that the PMA stimulation is responsible for the loss of expression of leukocyte markers on PBMC in this study. Whether a synergistic effect of PDB and IONO, as described in mice by Anderson & Coleclough (1993) , causes a more extensive and long-lasting downregulation of surface molecules in equine T-lymphocytes than PDB alone has not been determined as it remained outside the scope of this study.
We can conclude from this study that mitogen stimulation positively influences an EHV-1 infection in two ways : (i) by initiating specific cell cycle events and (ii) by inducing the formation of clusters of PBMC, thereby facilitating transmission of EHV-1 from cell to cell.
